FDA Import Refusal AEK-9640678-8/10002/1 — LUPIN LIMITED
The FDA refused shipment AEK-9640678-8/10002/1 from LUPIN LIMITED (India) on Sep 22, 2026. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 22, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75